Indian Markets

Nureca Ltd. - Buyback

Buyback Information
Company Name Nureca Ltd.
Record Date 12 Dec 2025
Issue Open Date 18 Dec 2025
Issue Close Date 24 Dec 2025
Buyback Type Tender Offer
Buyback Price ₹330.00 per share
Issue Size - Shares 580,000.00 Cr.
Issue Size - Amount ₹19.14 Cr.
Description
Incorporated in 2016, Nureca Limited is a healthcare and wellness company focused on making clinically reliable home healthcare products accessible to individuals, caregivers, and medical practitioners in India and select international markets. The company combines medical‑grade technology with consumer-friendly design to help people monitor, manage and improve their health from the comfort of their homes.

Nureca operates at the convergence of these trends by offering devices that can reduce dependence on frequent clinical visits and support continuous monitoring. The company’s digital‑led distribution, broad portfolio and consumer‑centric branding place it well to participate in the structural growth of India’s home healthcare category.
Nureca Limited Buyback 2025 Issue Timetable
Last Date to buy shares December 11, 2025
Offer Opens On December 18, 2025
Offer Closes On December 24, 2025
Last Date for settlement of bids January 1, 2026
Record Date December 12, 2025
Last Date for receipt of Tender Forms December 24, 2025
Finalisation of Buyback Acceptance December 30, 2025
Last Date for Extinguishment of Shares January 12, 2026
Buyback Ratio
Category Entitlement Ratio of Buyback Shares Offered
Reserved Category for Small Shareholders 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. 3,29,093
General Category for all other Eligible Shareholders 126 Equity Shares out of every 761 Fully paid-up Equity Shares held on the Record Date. 2,50,907

Amount in ₹ Crore

Necessity of the Issue

The Company is undertaking the Buyback after taking into account the Company's medium-term strategic and operational cash requirements, as well as the need to return surplus funds to the members in an effective and efficient manner. The proposed Buyback will help the Company achieve the following objectives:

  1. Optimise returns to shareholders; and
  2. Enhance overall shareholders' value. 2.2 The above objectives will be achieved through the Buyback process. They may lead to reduction in outstanding Equity Shares, improvement in earnings per Equity Share and enhanced return on invested capital. The Buyback will not, in any manner, impair the Company's ability to pursue growth opportunities or meet its cash requirements for business operations and continued capital investment, as and when required.
  3. The Buyback will help the Company to return surplus cash to its shareholders holding Equity Shares broadly in proportion to their shareholding, thereby, enhancing the overall return to shareholders;
  4. The Buyback, which is being implemented through the Tender Offer route as prescribed under the Buyback Regulations, would involve a reservation of up to 15% of the Equity Shares proposed to be brought back by the Company or the actual number of Equity Shares entitled as per the shareholding of small shareholders on the Record Date, whichever is higher. The Company believes that this reservation for small shareholders would benefit a significant number of the Company's public shareholders, who would be classified as 'Small Shareholders';
  5. The Buyback may help in improving return on equity, earnings per share by reduction in the equity base in the long term, thereby leading to long-term increase in shareholders' value; and
  6. The Buyback gives an option to the Eligible Shareholders to either (A) participate in the Buyback and receive cash in lieu of their Equity Shares, which are accepted under the BuyBack offer or (B) not to participate in the Buyback offer and get a resultant increase in their percentage shareholding in the Company post the BuyBack offer, without additional investment.
Nureca Limited Buyback 2025 Documents
US Markets